Pneumologie

Issue S 01 · Volume 73 · March 2019 DOI: 10.1055/s-009-42542

60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.
München, 13.–16.03.2019

Kongresspräsident: Prof. Dr. med. Jürgen Behr, München

Abstracts (HTML) List of Authors

Posterbegehung (P05) – Sektion Klinische Pneumologie

Asthma 2019

P296

Schulze, J; Smith, HJ; Eichhorn, C; Salzmann-Manrique, E; Dreßler, M; Zielen, S: Zusammenhang von Spirometrie und Bodyplethysmographie während einer Belastung induzierten bronchialen Obstruktion

Abstract
HTML

P327

Beck, E; Kaplan, A; Fitzgerald, JM; Azzi, GE; Engel, M; Buhl, R: Tiotropium provides greater improvements in FEV1 than leukotriene receptor antagonists as add-on to ICS in adults with asthma: a systematic review

Abstract
HTML

P400

Schultz, K; Wittmann, M; Wagner, R; Lehbert, N; Szentes, B; Schwarzkopf, L; Nowak, D; Faller, H; Schuler, M: Absolute Eosinophilenzahl und klinischer Verlauf von 333 konsekutiven Rehabilitanden mit nicht kontrolliertem Asthma

Abstract
HTML

P492

Munro, A; Vos, W; Mignot, B; Müllinger, B: Evaluierung von Lungendepositionsmustern für ICS mit verschiedenen Inhalationsgeräten in Patienten mit schwerem Asthma mittels eines In-Silico-Depositions-Modells

Abstract
HTML

P524

Mailänder, C: Omalizumab Selbstapplikation – Umfrage bei Ärzten und Patienten

Abstract
HTML

P601

Svedsater, H; Bosanquet, N; Jacques, L; Jones, R; LayFlurrie, J; Leather, DA; Vestbo, J; Woodcock, A: Effects of Fluticasone furoate/Vilanterol (FF/VI) on Patient Reported Outcomes (PRO): The Salford Lung Study in Asthma (SLS Asthma)

Abstract
HTML

P664

OʼByrne, P; Fitzgerald, JM; Bateman, E; Barnes, PJ; Zhong, N; Gustafson, P; Lamarca, R; Puu, M; Keen, C; Wang, M; Reddel, HK: Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma

Abstract
HTML

P714

Marth, K; Renner, A; Patocka, K; Pohl, W: Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria

Abstract
HTML

P254

Zangrilli, JG; Maspero, J; Harrison, T; Werkstrom, V; Wu, Y: Clinical Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma and Nasal Polyposis: Pooled Analysis of the SIROCCO and CALIMA Trials

Abstract
HTML

P261

Buhl, R; Heaney, L; Loefroth, E; Larbig, M; Konstantinos, K; Corti, V; Cao, H: Disease control and treatment pathways of asthma patients after initiating ICS/LABA

Abstract
HTML

P262

Beck, E; Fitzgerald, JM; Buhl, R; Casale, TB; Azzi, GE; Engel, M; Sigmund, R; Halpin, DMG: Tiotropium Respimat reduces episodes of asthma worsening in PrimoTinA-asthma, irrespective of baseline characteristics or season

Abstract
HTML

P464

Müllinger, B; Kolb, T; Gessler, T: Inhalationsgeräte mit kontrollierter Inhalation verbessern patientenrelevante Behandlungsergebnisse

Abstract
HTML

P530

Wiener, S; Wegner, S; Ernst, C: Cost Analysis of FeNO-based Asthma Management in Primary Care in Germany

Abstract
HTML

P558

Adamek, L; Plate, T; Shavit, A; Kanniess, F; Beier, J: DescRiption and charactErisation of asthmatiCs eligible for biolOGic therapy referral amoNg prImary and secondary care SEttings in Europe (RECOGNISE) study design, German part

Abstract
HTML

P236

Zangrilli, JG; Kamboj, A; Newbold, P; Hirsch, I: Characteristics of Patients With and Without Allergic Disease From Benralizumab Phase III Severe Asthma Trials

Abstract
HTML